Skip to main content
Medical information Clinical review pending

Dermatology Testing

Histopathology Direct Immunofluorescence DIF Skin Conjunctival Biopsy IgM Test

A specialized test using Direct Immunofluorescence (DIF) on skin or conjunctival biopsy samples to detect IgM antibodies, aiding in the diagnosis of autoimmune skin and eye conditions.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Skin or conjunctival biopsy specimen. Minimum size of 3 mm required. Specimen must be transported in a suitable transport medium for DIF (e.g., Michel's medium or saline) and kept refrigerated.
Results
Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required for the biopsy procedure itself. Patients should follow their doctor's instructions regarding the biopsy. Ensure the biopsy specimen is correctly labelled and accompanied by relevant clinical information.
Test priceKSh 1,287

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Histopathology Direct Immunofluorescence DIF Skin Conjunctival Biopsy IgM Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected autoimmune blistering disease (e.g., pemphigus, pemphigoid)
  • ✓Unexplained chronic skin rashes or blisters
  • ✓Persistent or recurrent conjunctivitis
  • ✓Evaluation of suspected immune-mediated skin or eye inflammation
  • ✓Diagnosis of lupus erythematosus involving skin or conjunctiva
  • ✓Confirmation of vasculitis affecting skin or conjunctiva
02

In plain language

What this test helps you understand

This test helps diagnose autoimmune blistering diseases and other immune-mediated dermatoses and conjunctival disorders by detecting IgM antibody deposition in tissue biopsies. It aids in differentiating between various autoimmune conditions affecting the skin and eyes, guiding appropriate treatment strategies.
The Histopathology Direct Immunofluorescence (DIF) Skin Conjunctival Biopsy IgM Test is a specialized diagnostic procedure used to investigate autoimmune disorders affecting the skin and eyes. This test involves examining a small tissue sample (biopsy) taken from the skin or conjunctiva (the membrane lining the eyelid and covering the white part of the eye). The sample is processed using cryotechnology and then examined under a fluorescence microscope. This allows our pathologists to detect the presence and pattern of specific antibodies, particularly IgM, deposited within the tissue. This information is crucial for diagnosing conditions like pemphigus vulgaris and bullous pemphigoid, which are autoimmune diseases where the body's immune system mistakenly attacks its own tissues. This test is often ordered when standard clinical examinations and other tests are inconclusive but an autoimmune condition is suspected.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required for the biopsy procedure itself. Patients should follow their doctor's instructions regarding the biopsy. Ensure the biopsy specimen is correctly labelled and accompanied by relevant clinical information.
SampleSkin or conjunctival biopsy specimen. Minimum size of 3 mm required. Specimen must be transported in a suitable transport medium for DIF (e.g., Michel's medium or saline) and kept refrigerated.
MethodologyDirect Immunofluorescence (DIF) microscopy on frozen sections of skin or conjunctival biopsy tissue.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
The test requires a properly collected and processed biopsy specimen. Results depend on the quality of the tissue sample and the expertise of the pathologist interpreting the fluorescence patterns. A negative result does not completely rule out an autoimmune condition, especially if the biopsy site was not actively involved or if the disease is intermittent.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

DIF is a laboratory technique that uses fluorescently labelled antibodies to detect specific proteins, like antibodies (IgM, IgG, IgA) or complement components, deposited in tissue samples.
A biopsy provides a tissue sample directly from the affected area (skin or conjunctiva), allowing for the detection of antibody deposits within the tissue itself, which is crucial for diagnosing certain autoimmune conditions.
The biopsy specimen must be transported in a special medium suitable for DIF and kept refrigerated to preserve the integrity of the antibodies for accurate testing. Please consult the laboratory for specific transport instructions.
A positive result indicates the presence of IgM antibodies deposited in the tissue. This finding, combined with clinical information and other test results, helps your doctor diagnose specific autoimmune conditions.
Turnaround time varies. Please contact the laboratory directly for the current estimated turnaround time for this specific test.
The biopsy procedure itself may cause some discomfort, similar to a minor pinch or sting. Your doctor will use local anaesthetic to minimize pain during the biopsy.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp